C12N 2517/02
Cells from transgenic animals
C12N2517/02 (Cells from transgenic animals) appears on 177 US grants and 307 published applications in this corpus.
Search patents in C12N- Granted patents
- 177
- Published applications
- 307
- Assignees
- 162
- Inventors
- 532
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 5 |
| 2002 | 5 | 24 |
| 2003 | 5 | 39 |
| 2004 | 6 | 25 |
| 2005 | 6 | 20 |
| 2006 | 9 | 37 |
| 2007 | 11 | 25 |
| 2008 | 7 | 13 |
| 2009 | 6 | 17 |
| 2010 | 10 | 6 |
| 2011 | 5 | 14 |
| 2012 | 9 | 4 |
| 2013 | 6 | 3 |
| 2014 | 4 | 9 |
| 2015 | 4 | 6 |
| 2016 | 5 | 6 |
| 2017 | 7 | 9 |
| 2018 | 5 | 10 |
| 2019 | 5 | 8 |
| 2020 | 5 | 3 |
| 2021 | 6 | 9 |
| 2022 | 6 | 3 |
| 2023 | 1 | 3 |
| 2024 | 4 | 2 |
| 2025 | 4 | 6 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production30 Jun 2026US 12,667,612 B2Fujifilm Biosciences Inc.
- Transgenic mouse models supporting innate immune function5 Aug 2025US 12,378,574 B2The Jackson Laboratory
- Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same13 May 2025US 12,297,458 B2Enfield
- Process of transfecting primordial germ cells in an avian25 Feb 2025US 12,232,488 B2Aviagen
- Process for using CRISPR to transfect primordial germ cells in avians4 Feb 2025US 12,213,466 B2Aviagen
- Cell adhesion system for interspecies chimeras2 Apr 2026US 2026/0092259 A1Board of Regents, The University of Texas System
- Transgenic mouse models supporting innate immune function20 Nov 2025US 2025/0354165 A1The Jackson Laboratory
- Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same30 Oct 2025US 2025/0333711 A1Alexis Bio, Inc.
- Genetically engineered innate lymphoid cells for enhancing lifespan and/or treating cancers4 Sep 2025US 2025/0276014 A1Academia Sinica
- Process of transfecting primordial germ cells in an avian15 May 2025US 2025/0151705 A1Aviagen
Most cited
By later US patents
- In vivo production of small interfering RNAS that mediate gene silencing253US 7,691,995 B2University of Massachusetts · 2010
- Method for generating an animal homozygous for a genetic modification199US 7,294,754 B2Regeneron Pharmaceuticals, Inc. · 2007
- Cloning using donor nuclei from proliferating somatic cells124US 5,945,577 AUniversity of Massachusetts as represented by its Amherst Campus · 1999
- Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene119US 6,632,976 B1Kirin Beer Kabushiki Kaisha · 2003
- Method for making homozygous genetic modifications111US 7,659,442 B2Regeneron Pharmaceuticals, Inc. · 2010